H. Lundbeck A/S
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 0ND5.IL | NBIX | 0MTD.IL | 4119.TW | ALKS | 000597.SZ | |
|---|---|---|---|---|---|---|
| Market cap | 55.31B | 16.81B | 178.72B | 6.05B | 7.71B | 6.41B |
| P/E (TTM) | 22.4 | 24.6 | 50.8 | 99.2 | — | 34.5 |
| Forward P/E | 25.1 | 13.9 | — | 9.0 | 25.4 | — |
| Price/book | 2.6 | 4.3 | 5.2 | 1.1 | 4.1 | 1.2 |
| Dividend yield | 1.58% | — | — | 1.47% | — | 1.23% |
| 1-year change | +20.02% | +7.27% | +46.92% | −9.43% | +44.85% | −20.28% |
| Today | +0.36% | +0.73% | +2.38% | −0.59% | +0.44% | +0.22% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All 0ND5.IL news ›H. Lundbeck A/S (OTCMKTS:HLUYY) Trading at $22.00
Posted by Tristan Rich on Oct 8th, 2026 H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report)’s stock price was down 0% during trading on Wednesday. The stock traded as low as $22.00 and last traded at $22.00. 7,500 shares were traded during…
H. Lundbeck A/S (HLUN_A) Reports Phase Ib Data; Starts Phase II in Parkinson's
TradingView H. Lundbeck A/S (HLUN_A) Reports Phase Ib Data; Starts Phase II in Parkinson's H. Lundbeck A/S presented Phase Ib data for Lu AF28996 in advanced Parkinson's disease and said a Phase II trial has begun. Conte
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- themarketsdaily.com1
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.